Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials

INTRODUCTION: Insulin degludec (degludec) is a basal insulin with an ultra-long, stable action profile and reduced pharmacodynamic variability. Seven phase 3a trials compared degludec with insulin glargine (glargine). Patient-level meta-analyses were performed to obtain a comprehensive overview of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Vora, Jiten, Christensen, Torsten, Rana, Azhar, Bain, Steve C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269648/
https://www.ncbi.nlm.nih.gov/pubmed/25081590
http://dx.doi.org/10.1007/s13300-014-0076-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269648/
https://www.ncbi.nlm.nih.gov/pubmed/25081590
http://dx.doi.org/10.1007/s13300-014-0076-9

Ejemplares similares